Discovery of dual-targeted molecules based on Olaparib and Rigosertib for triple-negative breast cancer with wild-type BRCA

Authors:

Abstract
No abstract available
Funding Information
  • National Natural Science Foundation of China
  • Natural Science Research of Jiangsu Higher Education Institutions of China

This publication has 39 references indexed in Scilit: